Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes
Please visit answersincme.com/860/98320325-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology discuss the evolving role of HER2-targeted antibody–drug conjugates (ADCs) and how to integrate them into clinical practice. Upon completion of this activity, participants should be better able to: Recognize the role of biomarker testing for the management of HER2-overexpressing NSCLC; Evaluate the clinical significance of new and emerging HER2-targeting ADCs for HER2-overexpressing NSCLC; and Apply strategies to optimize the use of HER2 targeting ADCs in patients with NSCLC.
-------- Â
55:02
--------
55:02
Matthew W. Martinez, MD, FACC, FASE / Brad Mehl, MHA, ACS, RDCS, RVT, RDMS, RT(R), FASE - The Echo Quest: Conquering Real-World Hypertrophic Cardiomyopathy Cases From Diagnosis to Treatment
Please visit answersincme.com/860/98750653-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in cardiology and cardiac sonography discuss best practices for using echocardiography for the diagnosis and management of obstructive hypertrophic cardiomyopathy, highlighting how echocardiography may guide treatment decisions with cardiac myosin inhibitors. Upon completion of this activity, participants should be better able to: Review guideline-recommended approaches to diagnose obstructive HCM; Evaluate how cardiac myosin inhibitors fit into the care of patients with obstructive HCM; Specify how echocardiogram may help guide treatment decisions for patients with HCM; and Outline strategies to optimally utilize echocardiography to monitor patients on cardiac myosin inhibitors.
-------- Â
1:19:06
--------
1:19:06
Scott Solomon, MD - Mapping the Future of Heart Failure Care: The Evolving Role of Nonsteroidal MRAs in the Treatment of Patients With Heart Failure and Mildly Reduced/Preserved Ejection Fraction
Please visit answersincme.com/QWE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in cardiology discusses the evolving role of mineralocorticoid receptor antagonists (MRAs) to treat patients with heart failure. Upon completion of this activity, participants should be better able to: Identify the evolving role of mineralocorticoid receptor antagonists (MRAs) to treat patients with heart failure; Evaluate clinical implications of the latest data on nonsteroidal MRAs for the treatment of heart failure and mildly reduced ejection fraction (HFmrEF) or heart failure and preserved ejection fraction (HFpEF), in the context of current standard-of-care; and Describe strategies to incorporate nonsteroidal MRAs into the treatment plans of patients with HFmrEF or HFpEF.
-------- Â
18:05
--------
18:05
Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World
Please visit answersincme.com/860/97851223-replay1 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in lung cancer discuss the practical application of immunotherapy-based regimens for the treatment of extensive-stage small-cell lung cancer (ES-SCLC). Upon completion of this activity, participants should be better able to: Review the clinical impact of immunotherapy-based regimens for the management of small-cell lung cancer (SCLC); and Outline personalized treatment strategies to address key complexities affecting the optimal, real-world management of patients with SCLC.
-------- Â
28:17
--------
28:17
David E. Griffith, MD - Guiding Principles in the Management of Refractory Mycobacterium Avium Complex (MAC) Pulmonary Disease: Casing the Evidence to Inform Practical Care
Please visit answersincme.com/FXP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in pulmonary infectious disease discusses management of refractory Mycobacterium avium complex (MAC) pulmonary disease. Upon completion of this activity, participants should be better able to: Identify patients with refractory Mycobacterium avium complex (MAC) pulmonary disease in a timely manner; Review guideline-recommended therapeutic approaches to enhance the treatment plan for patients with refractory MAC pulmonary disease; and Outline clinical strategies to optimize long-term care for patients with refractory MAC pulmonary disease.
About CME in Minutes: Education in Cardiology & Pulmonology
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Cardiology & Pulmonology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in cardiology, pulmonology. Earning your CME/CE credit has never been faster or easier. Download the URL for each individual program to request continuing education credit or access the slides.
Listen to CME in Minutes: Education in Cardiology & Pulmonology, The Psychology of your 20s and many other podcasts from around the world with the radio.net app
South Africa